These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15500393)

  • 21. 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique, differential effects on the vasculature, bone and uterus.
    Somjen D; Amir-Zaltsman Y; Gayer B; Kulik T; Knoll E; Stern N; Lu LJ; Toldo L; Kohen F
    J Endocrinol; 2002 Jun; 173(3):415-27. PubMed ID: 12065231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selective estrogen receptor modulators (SERMs) in the practice].
    Nagykálnai T
    Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective estrogen receptor modulators in breast cancer prevention.
    Li F; Dou J; Wei L; Li S; Liu J
    Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective estrogen receptor modulators: tissue selectivity and differential uterine effects.
    Silfen SL; Ciaccia AV; Bryant HU
    Climacteric; 1999 Dec; 2(4):268-83. PubMed ID: 11910661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
    Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the oestrogen receptor: a process with distinct susceptible steps.
    Cano A; Hermenegildo C
    Hum Reprod Update; 2000; 6(3):207-11. PubMed ID: 10874565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of breast cancer with selective oestrogen-receptor modulators.
    Jordan VC
    Nat Rev Cancer; 2007 Jan; 7(1):46-53. PubMed ID: 17186017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Physiopathology of bone loss and pharmacologic approach of selective estrogen receptor modulators].
    de Vernejoul MC; Cohen-Solal M; Bénichou O
    Joint Bone Spine; 2000; 67 Suppl 1():7s-13s. PubMed ID: 10769109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms of selective estrogen receptor modulator (SERM) action.
    Dutertre M; Smith CL
    J Pharmacol Exp Ther; 2000 Nov; 295(2):431-7. PubMed ID: 11046073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients.
    Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G
    Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease.
    Jordan VC; Gapstur S; Morrow M
    J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
    Xu B; Lovre D; Mauvais-Jarvis F
    J Diabetes Complications; 2017 Apr; 31(4):773-779. PubMed ID: 28185712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of SERMs on breast tissue.
    Goldstein SR
    J Endocrinol Invest; 1999 Sep; 22(8):636-40. PubMed ID: 10532251
    [No Abstract]   [Full Text] [Related]  

  • 35. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
    Sengupta S; Jordan VC
    Adv Exp Med Biol; 2008; 630():206-19. PubMed ID: 18637493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of chronic estradiol, tamoxifen or raloxifene treatment on serotonin 5-HT1A receptor.
    Landry M; Di Paolo T
    Brain Res Mol Brain Res; 2003 Apr; 112(1-2):82-9. PubMed ID: 12670705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where do selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) now fit into breast cancer treatment algorithms?
    Howell A; Howell SJ; Clarke R; Anderson E
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):227-37. PubMed ID: 11850229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular mechanisms involved in the protective actions of Selective Estrogen Receptor Modulators in brain cells.
    Baez-Jurado E; Rincón-Benavides MA; Hidalgo-Lanussa O; Guio-Vega G; Ashraf GM; Sahebkar A; Echeverria V; Garcia-Segura LM; Barreto GE
    Front Neuroendocrinol; 2019 Jan; 52():44-64. PubMed ID: 30223003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine manipulation in advanced breast cancer: recent advances with SERM therapies.
    Johnston SR
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4376s-4387s; discussion 4411s-4412s. PubMed ID: 11916228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.